1. Home
  2. NEOG vs PGEN Comparison

NEOG vs PGEN Comparison

Compare NEOG & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neogen Corporation

NEOG

Neogen Corporation

HOLD

Current Price

$8.38

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$3.26

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEOG
PGEN
Founded
1981
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.6B
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
NEOG
PGEN
Price
$8.38
$3.26
Analyst Decision
Buy
Buy
Analyst Count
4
5
Target Price
$10.67
$7.67
AVG Volume (30 Days)
2.2M
3.7M
Earning Date
04-08-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$894,661,000.00
$230,981,000.00
Revenue This Year
N/A
$342.78
Revenue Next Year
$1.67
$478.46
P/E Ratio
$96.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.87
$1.11
52 Week High
$11.43
$5.47

Technical Indicators

Market Signals
Indicator
NEOG
PGEN
Relative Strength Index (RSI) 24.98 36.48
Support Level $4.74 $2.99
Resistance Level $10.30 $5.10
Average True Range (ATR) 0.47 0.18
MACD -0.24 0.00
Stochastic Oscillator 0.87 24.53

Price Performance

Historical Comparison
NEOG
PGEN

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: